SA518391908B1 - مرهم يشتمل على مركب أوكسازول محدد - Google Patents
مرهم يشتمل على مركب أوكسازول محددInfo
- Publication number
- SA518391908B1 SA518391908B1 SA518391908A SA518391908A SA518391908B1 SA 518391908 B1 SA518391908 B1 SA 518391908B1 SA 518391908 A SA518391908 A SA 518391908A SA 518391908 A SA518391908 A SA 518391908A SA 518391908 B1 SA518391908 B1 SA 518391908B1
- Authority
- SA
- Saudi Arabia
- Prior art keywords
- ointment
- oxazole compound
- specific oxazole
- specific
- compound
- Prior art date
Links
- 239000002674 ointment Substances 0.000 title abstract 4
- -1 Oxazole Compound Chemical class 0.000 title abstract 2
- 101100296720 Dictyostelium discoideum Pde4 gene Proteins 0.000 abstract 1
- 101100082610 Plasmodium falciparum (isolate 3D7) PDEdelta gene Proteins 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
يتعلق الاختراع الحالي بتوفير مرهم ointment. يشتمل المرهم بشكل مستقر على مركب أوكسازول oxazole حيث يكون له نشاط تثبيطي inhibitory activity معين ضد PDE4 ويتم عرضه بواسطة الصيغة التالية (11). يمكن امتصاص المرهم ointment بفعالية في الجلد skin.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015256784 | 2015-12-28 | ||
PCT/JP2016/088843 WO2017115780A1 (en) | 2015-12-28 | 2016-12-27 | Ointment |
Publications (1)
Publication Number | Publication Date |
---|---|
SA518391908B1 true SA518391908B1 (ar) | 2022-06-05 |
Family
ID=57851287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SA518391908A SA518391908B1 (ar) | 2015-12-28 | 2018-06-27 | مرهم يشتمل على مركب أوكسازول محدد |
Country Status (16)
Country | Link |
---|---|
US (3) | US10588893B2 (ar) |
EP (1) | EP3397619B1 (ar) |
JP (3) | JP6873128B2 (ar) |
KR (2) | KR20240034867A (ar) |
CN (1) | CN108473448A (ar) |
AU (1) | AU2016382036B2 (ar) |
CA (1) | CA3009734A1 (ar) |
DK (1) | DK3397619T3 (ar) |
ES (1) | ES2811849T3 (ar) |
HK (1) | HK1255187A1 (ar) |
MY (1) | MY197975A (ar) |
PH (1) | PH12018501346A1 (ar) |
SA (1) | SA518391908B1 (ar) |
SG (2) | SG11201805364TA (ar) |
TW (1) | TWI726027B (ar) |
WO (1) | WO2017115780A1 (ar) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202012380A (zh) | 2018-04-04 | 2020-04-01 | 日商大塚製藥股份有限公司 | 唑化合物晶體 |
JP7051968B2 (ja) * | 2019-10-09 | 2022-04-11 | 大塚製薬株式会社 | オキサゾール化合物結晶 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6419963B1 (en) * | 2001-04-22 | 2002-07-16 | Sarfaraz K Niazi | Composition and method for the treatment of diaper rash using natural products |
US7655717B2 (en) * | 2002-07-17 | 2010-02-02 | Mary J. Goulbourne | Ointment composition for treating decubitus ulcers and methods for its making and its use |
TW200418516A (en) * | 2003-02-21 | 2004-10-01 | Shionogi & Co | Droplet dispersed ointment |
MY153720A (en) * | 2005-11-15 | 2015-03-13 | Otsuka Pharma Co Ltd | Oxazole compound and pharmaceutical composition |
US8575189B2 (en) * | 2008-10-08 | 2013-11-05 | Takata Seiyaku Co., Ltd. | Tacrolimus preparation for external applications |
GB0907413D0 (en) * | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
JP5965187B2 (ja) * | 2012-03-30 | 2016-08-03 | 小林製薬株式会社 | 油性軟膏剤 |
CN109879828A (zh) | 2012-08-30 | 2019-06-14 | 大塚制药株式会社 | 制造噁唑化合物的方法 |
-
2016
- 2016-12-26 TW TW105143190A patent/TWI726027B/zh active
- 2016-12-27 JP JP2018525638A patent/JP6873128B2/ja active Active
- 2016-12-27 US US16/064,618 patent/US10588893B2/en active Active
- 2016-12-27 WO PCT/JP2016/088843 patent/WO2017115780A1/en active Application Filing
- 2016-12-27 ES ES16828990T patent/ES2811849T3/es active Active
- 2016-12-27 CA CA3009734A patent/CA3009734A1/en active Pending
- 2016-12-27 AU AU2016382036A patent/AU2016382036B2/en active Active
- 2016-12-27 KR KR1020247006977A patent/KR20240034867A/ko not_active Application Discontinuation
- 2016-12-27 EP EP16828990.8A patent/EP3397619B1/en active Active
- 2016-12-27 DK DK16828990.8T patent/DK3397619T3/da active
- 2016-12-27 KR KR1020187020807A patent/KR102643824B1/ko active IP Right Grant
- 2016-12-27 MY MYPI2018001102A patent/MY197975A/en unknown
- 2016-12-27 SG SG11201805364TA patent/SG11201805364TA/en unknown
- 2016-12-27 CN CN201680076557.0A patent/CN108473448A/zh active Pending
- 2016-12-27 SG SG10201912634QA patent/SG10201912634QA/en unknown
-
2018
- 2018-06-22 PH PH12018501346A patent/PH12018501346A1/en unknown
- 2018-06-27 SA SA518391908A patent/SA518391908B1/ar unknown
- 2018-11-08 HK HK18114305.1A patent/HK1255187A1/zh unknown
-
2020
- 2020-02-05 US US16/782,259 patent/US20200171006A1/en not_active Abandoned
-
2021
- 2021-04-19 JP JP2021070099A patent/JP2021107437A/ja active Pending
-
2022
- 2022-01-03 US US17/567,582 patent/US20220117944A1/en active Pending
-
2023
- 2023-02-07 JP JP2023016555A patent/JP2023058571A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3397619A1 (en) | 2018-11-07 |
NZ743851A (en) | 2021-09-24 |
AU2016382036A1 (en) | 2018-07-12 |
KR102643824B1 (ko) | 2024-03-07 |
WO2017115780A1 (en) | 2017-07-06 |
TW201729806A (zh) | 2017-09-01 |
EP3397619B1 (en) | 2020-07-29 |
PH12018501346B1 (en) | 2019-02-18 |
AU2016382036B2 (en) | 2021-02-04 |
ES2811849T3 (es) | 2021-03-15 |
US20190000810A1 (en) | 2019-01-03 |
CN108473448A (zh) | 2018-08-31 |
US10588893B2 (en) | 2020-03-17 |
JP2023058571A (ja) | 2023-04-25 |
HK1255187A1 (zh) | 2019-08-09 |
SG11201805364TA (en) | 2018-07-30 |
MY197975A (en) | 2023-07-25 |
US20200171006A1 (en) | 2020-06-04 |
JP2021107437A (ja) | 2021-07-29 |
TWI726027B (zh) | 2021-05-01 |
KR20180097672A (ko) | 2018-08-31 |
PH12018501346A1 (en) | 2019-02-18 |
KR20240034867A (ko) | 2024-03-14 |
CA3009734A1 (en) | 2017-07-06 |
DK3397619T3 (da) | 2020-08-24 |
SG10201912634QA (en) | 2020-02-27 |
JP2019503989A (ja) | 2019-02-14 |
JP6873128B2 (ja) | 2021-05-19 |
US20220117944A1 (en) | 2022-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201701299B (en) | Glycosidase inhibitors | |
MX2019012096A (es) | Inhibidor de melanogenesis que comprende alcohol d-pantotenilico, y cosmetico de blanqueamiento de la piel que contiene el mismo inhibidor de melanogenesis. | |
NZ732799A (en) | Picolinamides with fungicidal activity | |
MX2015005694A (es) | Administracion de vehiculo compartido. | |
AU2015299431B2 (en) | Pyrrolidinone derivatives as metAP-2 inhibitors | |
PH12016501252A1 (en) | Novel tetrahydropyridopyrimidine compound or salt thereof | |
MX2017013880A (es) | Derivados del acido tetrahidronaftiridinil propionico y usos de los mismos. | |
MX2016013894A (es) | Composicion para el cuidado del cuero cabelludo. | |
MX2015011837A (es) | Co-cristale de pirimetanil y tetracarboximida de ditiina seleccionada. | |
ZA201704116B (en) | 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2h-pyrrol-5-amine compound inhibitors of beta-secretase | |
MY186907A (en) | Hair growth agent | |
MX2017006709A (es) | Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales. | |
MX2016012689A (es) | Piridin-2-amidas utiles como agonistas del receptor 2 cannabinoide (cb2). | |
SG10201805896SA (en) | PPARγ AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS | |
MX371128B (es) | Compuestos de dihidropirimidin-2-ona y su uso medico. | |
EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
SA518391908B1 (ar) | مرهم يشتمل على مركب أوكسازول محدد | |
MX2017006712A (es) | Inhibidor de produccion de metaloproteinasa de matriz. | |
GEP20186893B (en) | Pyrazines modulators of gpr6 | |
MY178960A (en) | Hiv treatment formulation of atazanavir and cobicistat | |
MX2018003903A (es) | Compuesto biciclico y uso del mismo para inhibicion de suv39h2. | |
MX2016011310A (es) | Agente para el control de endoparasitos. | |
MX2016011308A (es) | Agente para el control de endoparasitos. | |
WO2014118304A3 (en) | A support member for cooking devices and the cooking device wherein the same is used | |
UA114627U (xx) | КОМПЛЕКСНА СПОЛУКА НА ОСНОВІ ТЕТРАХЛОРИДУ ОЛОВА ІЗ САЛІЦИЛАЛЬ-n-ТОЛУЇДИНОМ ЯК ПРИСАДКА ДЛЯ ІНГІБУВАННЯ ОКИСНЕННЯ БЕНЗИЛОВОГО СПИРТУ |